Cardiomyopathy associated with clozapine

Experimental and Clinical Psychopharmacology

Volumn 14, Issue 1, 2006, Pages 94-98

  Roh, Sungwon ^a   Ahn, Dong Hyun ^a   Nam, Jung Hyun ^a   Yang, Byung Hwan ^a   Lee, Bang Hun ^a   Kim, Yang Suk ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Cardiac complications; Cardiomyopathy; Clozapine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HALOPERIDOL; INOTROPIC AGENT; OLANZAPINE;

ADULT; ARTICLE; CARDIOMEGALY; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; DRUG SAFETY; ELECTROCARDIOGRAM; GENERAL CONDITION IMPROVEMENT; HEART ATRIUM HYPERTROPHY; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LUNG CONGESTION; MALE; MITRAL VALVE REGURGITATION; PATIENT CARE; RECURRENT DISEASE; RELAPSE; SCHIZOPHRENIA; THORAX RADIOGRAPHY; TRICUSPID VALVE REGURGITATION; VIRUS INFECTION;

ADULT; ANTIPSYCHOTIC AGENTS; CARDIOMYOPATHY, DILATED; CLOZAPINE; HUMANS; MALE; SCHIZOPHRENIA;

EID: 33644603058     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.14.1.94     Document Type: Article

References (17)

1. Bandelow, B., Degner, D., Kreusch, U., & Ruther, E. (1995). Myocarditis under therapy with clozapine. Schizophrenia Research, 17, 293-294.
2. Committee on Safety of Medicines. (1993). Myocarditis with antipsychotics: Recent cases with clozapine (Clozaril). Current Problems in Pharmacovigilance, 19, 9-10.
3. Coulter, D. M., Bate, A., Meyboom, R. H., Lindquist, M., & Edwards, I. R. (2001). Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: Data mining study. British Medical Journal, 322, 1207-1209.
4. Degner, D., Bleich, S., Grohmann, R., Bandelow, B., & Ruther, E. (2000). Myocarditis associated with clozapine treatment. Australian and New Zealand Journal of Psychiatry, 34, 880.
5. Foster, B. C., Vandenhoek, S., Tang, R., Budzinski, J. W., Krantis, A., & Li, K. Y. (2002). Effect of several Chinese natural health products of human cytochrome P450 metabolism. Journal of Pharmacy & Pharmaceutical Sciences, 5, 185-189.
6. Grohmann, R., Rüther, E., Engel, R. R., & Hippius, H. (1999). Assessment of adverse drug reactions in psychiatric inpatients with AMSP Drug Safety Program: Methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiatry, 32, 21-28.
7. Hägg, S., Spigset, O., Bate, A., & Soderstrom, T. G. (2001). Myocarditis related to clozapine treatment. Journal of Clinical Psychopharmacology, 21, 382-388.
8. Johansson, I., Oscarson, M., Yue, Q. Y., Bertilsson, L., Sjoqvist, F., & Ingelman-Sundberg, M. (1994). Genetic analysis of the Chinese cytochrome P4502D locus: Characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Molecular Pharmacology, 46, 452-459.
9. Kilian, J. G., Kerr, K., Lawrence, C., & Celermajer, D. S. (1999, November 27). Myocarditis and cardiomyopathy associated with clozapine. Lancet, 354, 1841-1845.
10. Kwon, J. S., Kim, E. T., Ha, T. H., Roh, K. S., Choi, J. S., & Kim, Y. S. (2003). Drug prescribing patterns of outpatients with schizophrenia in a university hospital. Journal of Korean Neuropsychiatric Association, 42, 683-690.
11. La Grenade, L., Graham, D., & Trontell, A. (2001). Myocarditis and cardiomyopathy associated with clozapine use in the United States. New England Journal of Medicine, 345, 224-225.
12. Liou, Y. J., Liao, D. L., Chen, J. Y., Wang, Y. C., Lin, C. C., Bai, Y. M., et al. (2004). Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Medicine, 5, 243-251.
13. Someya, T., Shimoda, K., Suzuki, Y., Sato, S., Kawashima, Y., Hirokane, G., et al. (2003). Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population. Neuropsychopharmacology, 28, 1501-1505.
14. Thomson Healthcare. (2005). Physicians' desk reference (59th ed.). Stamford, CT: Author.
15. Vaddadi, K. S., Soosai, E., & Vaddadi, G. (2003). Low blood selenium concentrations in schizophrenic patients on clozapine. British Journal of Clinical Pharmacology, 55, 307-309.
16. Wehmeier, P. M., Heiser, P., & Remschmidt, H. (2005). Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. Journal of Clinical Pharmacy and Therapeutics, 30, 91-96.
17. Wooltorton, E. (2002). Antipsychotic clozapine (Clozaril): myocarditis and cardiovascular toxicity. Canadian Medical Association Journal, 166, 1185-1186.